Show simple item record

dc.contributor.authorCrowley, Lisa
dc.contributor.authorJohnson, CP
dc.contributor.authorMcIntyre, Natasha
dc.contributor.authorFluck, Richard
dc.contributor.authorMcIntyre, Christopher
dc.contributor.authorTaal, Maarten
dc.contributor.authorLeung, Janson
dc.date.accessioned2016-10-06T15:47:23Z
dc.date.available2016-10-06T15:47:23Z
dc.date.issued2013-10
dc.identifier.citationNephron Clin Pract. 2013;124(1-2):54-9. doi: 10.1159/000355692. Epub 2013 Oct 15.language
dc.identifier.urihttp://hdl.handle.net/20.500.12904/640
dc.descriptionAuthor(s) Pre or Post Print Version Only.language
dc.description.abstractBACKGROUND: Tissue advanced glycation end products (AGEs) accumulate in chronic kidney disease (CKD) and are a measure of cumulative metabolic stress. Measurement of tissue AGEs by skin autofluorescence (SAF) correlates well with cardiovascular outcomes in dialysis patients. SAF levels in transplant recipients relative to CKD and dialysis patients have not been previously studied, and the impact of transplantation on SAF levels in dialysis patients is unknown. METHODS: SAF was measured using an AGE reader in 66 patients who had received a kidney transplant. Values were compared to those obtained in 1,707 patients with CKD stage 3 and in 115 patients on dialysis. RESULTS: Mean SAF in transplant recipients [2.81 ± 0.64 arbitrary units (AU)] was significantly lower than in patients on haemodialysis (3.73 ± 0.88 AU) and peritoneal dialysis (3.57 ± 0.75 AU; p < 0.001), but was no different from CKD stage 3 (2.79 ± 0.66 AU; p = 0.42). In the transplant group, SAF correlated most strongly with age (r = 0.316). There was no correlation between SAF and estimated glomerular filtration rate or renal replacement therapy vintage. A small cohort of patients with SAF recorded on dialysis and following transplantation showed a drop in SAF over a mean time of 16 months after transplantation. DISCUSSION: Tissue AGE values in kidney transplant recipients are significantly lower than in patients receiving dialysis and similar to those in patients with CKD stage 3. Our data suggest that transplantation may be associated with a reduction in tissue AGEs, and this might be an important component of the observed reduction in cardiovascular risk in transplant recipients compared to patients on dialysis.language
dc.language.isoenlanguage
dc.subjectChronic Kidney Diseaselanguage
dc.subjectKidney Transplantationlanguage
dc.titleTissue advanced glycation end product deposition after kidney transplantation.language
dc.typeArticlelanguage


This item appears in the following Collection(s)

Show simple item record